Cost-Effectiveness Analysis of Interferon Beta in Multiple Sclerosis: A Markov Process Analysis
- 1 January 2002
- journal article
- research article
- Published by Elsevier in Value in Health
- Vol. 5 (1) , 44-54
- https://doi.org/10.1046/j.1524-4733.2002.51052.x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Multiple SclerosisNew England Journal of Medicine, 2000
- Economic Evaluation of Multiple Sclerosis in the UK, Germany and FrancePharmacoEconomics, 1998
- Therapeutic advances: beta-interferon for multiple sclerosisJournal of Clinical Pharmacy & Therapeutics, 1996
- Use and misuse of statistics for epidemiological studies of multiple sclerosisAnnals of Neurology, 1994
- Quality of Life in Multiple SclerosisArchives of Neurology, 1992
- Economic status of families living with multiple sclerosisInternational Journal of Rehabilitation Research, 1992
- Cognitive dysfunction in multiple sclerosis.Neurology, 1991
- THE NATURAL HISTORY OF MULTIPLE SCLEROSIS: A GEOGRAPHICALLY BASED STUDYBrain, 1989
- Exacerbation Rates and Adherence to Disease Type in a Prospectively Followed-up Population With Multiple SclerosisArchives of Neurology, 1989
- THE NATURAL HISTORY OF MULTIPLE SCLEROSIS: A GEOGRAPHICALLY BASED STUDYBrain, 1989